Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spherix Global Insights
Marketing
AbbVie’s Skyrizi passes Lilly’s Omvoh to take lead in colitis
Spherix said Skyrizi has quickly blasted past Omvoh in ulcerative colitis, capturing more than double the market share two months after launch.
Nick Paul Taylor
Oct 7, 2024 10:53am
Docs discuss ongoing Humira use, name preferred biosimilars
Sep 24, 2024 7:20am
Off-label drugs fall out of favor in lupus
Jun 16, 2023 10:16am
Eisai's Leqembi gaining ground with US neurologists
Apr 11, 2023 10:00am
Docs 'cautious' about GSK's new anemia drug: survey
Feb 9, 2023 2:52pm
BMS' Zeposia, AbbVie drugs shake up early IBD market
Dec 6, 2022 9:25am
